Can we predict who will worsen in PBC? a new study aims to find out
NCT ID NCT07733882
First seen Jul 29, 2026 · Last updated Aug 05, 2026 · Updated 3 times
Summary
This study looks at people with primary biliary cholangitis (PBC), a chronic liver disease that can lead to cirrhosis and liver failure. Researchers will review medical records from hundreds of patients to identify risk factors for faster disease progression. The goal is to build a prediction model that helps doctors spot high-risk patients early and personalize their care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a risk prediction model that helps doctors identify high-risk PBC patients early and tailor their treatment and follow-up.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't test any new therapy. The model may need further validation before it can be used in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PBC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Ditan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100015, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.